Siolta Therapeutics is Biotechnology in United States that focus on therapeutics leverages business. Founded in 2016. They cover business area such as developer, human microbiome therapeutic, inflammatory disease, knowledge, gut microbiome, its role, immune tolerance, target microbial therapy, companion diagnostic, treatment, medical researcher, information, human microbiome study, inflammatory process.
2016
( 8 years old in 2024 )
Therapeutics Leverages
-
930 Brittan Avenue
San Carlos, CA 94070
United States
Private
developerhuman microbiome therapeuticinflammatory diseaseknowledgegut microbiomeits roleimmune tolerancetarget microbial therapycompanion diagnostictreatmentmedical researcherinformationhuman microbiome studyinflammatory process
* We use standard office opening hours in near Siolta Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Siolta Therapeutics is Biotechnology business from United States that founded in 2016 (8 years old in 2024), Siolta Therapeutics business is focusing on Therapeutics Leverages.
Siolta Therapeutics headquarter office and corporate office address is located in 930 Brittan Avenue San Carlos, CA 94070 United States.
Siolta Therapeutics was founded in United States.
In 2024, Siolta Therapeutics is currently focus on therapeutics leverages sector.
Above is snippet of Google Trends for "therapeutics leverages" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Siolta Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
